BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 21482137)

  • 21. Uterine Artery Embolization of Uterine Leiomyomas: Predictive MRI Features of Volumetric Response.
    Kurban LAS; Metwally H; Abdullah M; Kerban A; Oulhaj A; Alkoteesh JA
    AJR Am J Roentgenol; 2021 Apr; 216(4):967-974. PubMed ID: 33594913
    [No Abstract]   [Full Text] [Related]  

  • 22. Dynamic contrast-enhanced magnetic resonance imaging predicts immediate therapeutic response of magnetic resonance-guided high-intensity focused ultrasound ablation of symptomatic uterine fibroids.
    Kim YS; Lim HK; Kim JH; Rhim H; Park BK; Keserci B; Köhler MO; Bae DS; Kim BG; Lee JW; Kim TJ; Sokka S; Lee JH
    Invest Radiol; 2011 Oct; 46(10):639-47. PubMed ID: 21654495
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Focused Ultrasound Myoma Outcome Study (FUMOS); a retrospective cohort study on long-term outcomes of MR-HIFU therapy.
    Verpalen IM; de Boer JP; Linstra M; Pol RLI; Nijholt IM; Moonen CTW; Bartels LW; Franx A; Boomsma MF; Braat MNG
    Eur Radiol; 2020 May; 30(5):2473-2482. PubMed ID: 32040725
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term outcome of MR-guided focused ultrasound treatment and laparoscopic myomectomy for symptomatic uterine fibroid tumors.
    Mohr-Sasson A; Machtinger R; Mashiach R; Nir O; Inbar Y; Maliyanker N; Goldenberg M; Rabinovici J
    Am J Obstet Gynecol; 2018 Oct; 219(4):375.e1-375.e7. PubMed ID: 30217580
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcome of uterine artery embolization versus MR-guided high-intensity focused ultrasound treatment for uterine fibroids: long-term results.
    Froeling V; Meckelburg K; Schreiter NF; Scheurig-Muenkler C; Kamp J; Maurer MH; Beck A; Hamm B; Kroencke TJ
    Eur J Radiol; 2013 Dec; 82(12):2265-9. PubMed ID: 24075785
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Entropy of T2-weighted imaging combined with apparent diffusion coefficient in prediction of uterine leiomyoma volume response after uterine artery embolization.
    Cao MQ; Suo ST; Zhang XB; Zhong YC; Zhuang ZG; Cheng JJ; Chi JC; Xu JR
    Acad Radiol; 2014 Apr; 21(4):437-44. PubMed ID: 24594413
    [TBL] [Abstract][Full Text] [Related]  

  • 27. T2*-weighted imaging in the assessment of the non-perfused volume of uterine fibroids following magnetic resonance-guided high-intensity focused ultrasound ablation.
    Liu J; Wei J; Keserci B; Zhang J; Yang X; Wang X
    Int J Gynaecol Obstet; 2016 Jan; 132(1):100-2. PubMed ID: 26475075
    [No Abstract]   [Full Text] [Related]  

  • 28. Magnetic resonance imaging-guided focused ultrasound ablation of uterine fibroids: early clinical experience.
    Mikami K; Murakami T; Okada A; Osuga K; Tomoda K; Nakamura H
    Radiat Med; 2008 May; 26(4):198-205. PubMed ID: 18509719
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Magnetic Resonance Imaging Parameters in Predicting the Treatment Outcome of High-intensity Focused Ultrasound Ablation of Uterine Fibroids With an Immediate Nonperfused Volume Ratio of at Least 90.
    Keserci B; Duc NM
    Acad Radiol; 2018 Oct; 25(10):1257-1269. PubMed ID: 29525424
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Leiomyoma shrinkage after MRI-guided focused ultrasound treatment: report of 80 patients.
    LeBlang SD; Hoctor K; Steinberg FL
    AJR Am J Roentgenol; 2010 Jan; 194(1):274-80. PubMed ID: 20028933
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incidence of nonviable leiomyomas on contrast material-enhanced pelvic MR imaging in patients referred for uterine artery embolization.
    Nikolaidis P; Siddiqi AJ; Carr JC; Vogelzang RL; Miller FH; Chrisman HB; Nemcek AA; Omary RA
    J Vasc Interv Radiol; 2005 Nov; 16(11):1465-71. PubMed ID: 16319152
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diffusion-weighted MR imaging of uterine leiomyomas following uterine artery embolization.
    Sutter O; Soyer P; Shotar E; Dautry R; Guerrache Y; Placé V; Opréa R; Ricbourg A; Le Dref O; Boudiaf M; Sirol M; Dohan A
    Eur Radiol; 2016 Oct; 26(10):3558-70. PubMed ID: 26801165
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Uterine artery embolization for leiomyomas: percentage of infarction predicts clinical outcome.
    Kroencke TJ; Scheurig C; Poellinger A; Gronewold M; Hamm B
    Radiology; 2010 Jun; 255(3):834-41. PubMed ID: 20392986
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preservation of the endometrial enhancement after magnetic resonance imaging-guided high-intensity focused ultrasound ablation of submucosal uterine fibroids.
    Kim YS; Kim TJ; Lim HK; Rhim H; Jung SH; Ahn JH; Lee JW; Kim BG
    Eur Radiol; 2017 Sep; 27(9):3956-3965. PubMed ID: 28210800
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PROMISe trial: a pilot, randomized, placebo-controlled trial of magnetic resonance guided focused ultrasound for uterine fibroids.
    Jacoby VL; Kohi MP; Poder L; Jacoby A; Lager J; Schembri M; Rieke V; Grady D; Vittinghoff E; Coakley FV
    Fertil Steril; 2016 Mar; 105(3):773-780. PubMed ID: 26658133
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term outcome of uterine artery embolization for symptomatic uterine leiomyomas.
    Lohle PN; Voogt MJ; De Vries J; Smeets AJ; Vervest HA; Lampmann LE; Boekkooi PF
    J Vasc Interv Radiol; 2008 Mar; 19(3):319-26. PubMed ID: 18295689
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Apparent diffusion coefficient of uterine leiomyoma as a predictor of the potential response to uterine artery embolization.
    Lee MS; Kim MD; Jung DC; Lee M; Won JY; Park SI; Lee DY; Lee KH
    J Vasc Interv Radiol; 2013 Sep; 24(9):1361-5. PubMed ID: 23891046
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The safety and efficacy of add-on use of oxytocin in uterine leiomyoma patients undergoing high-intensity focused ultrasound and ultrasound-guided intratumoral ethanol injection: a randomized controlled trial.
    Zhang R; Zhang Y; Yang Z; Chen J; Wang Q; Ma J; Zhang B; Zhang H
    Ann Palliat Med; 2022 Jun; 11(6):2033-2042. PubMed ID: 35817738
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Magnetic resonance imaging-guided volumetric ablation of symptomatic leiomyomata: correlation of imaging with histology.
    Venkatesan AM; Partanen A; Pulanic TK; Dreher MR; Fischer J; Zurawin RK; Muthupillai R; Sokka S; Nieminen HJ; Sinaii N; Merino M; Wood BJ; Stratton P
    J Vasc Interv Radiol; 2012 Jun; 23(6):786-794.e4. PubMed ID: 22626269
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Uterine fibroids: semiquantitative perfusion MR imaging parameters associated with the intraprocedural and immediate postprocedural treatment efficiencies of MR imaging-guided high-intensity focused ultrasound ablation.
    Kim YS; Kim BG; Rhim H; Bae DS; Lee JW; Kim TJ; Choi CH; Lee YY; Lim HK
    Radiology; 2014 Nov; 273(2):462-71. PubMed ID: 24988436
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.